Around a third of people not already using GLP-1 medications (32%) said they would like to lose weight but still are not planning to begin using GLP-1s
Age shapes expectations and experiences Satisfaction also varies sharply by age
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Sources Alvin Francisco Official Tiktok Account (@docalvinfrancisco), Tiktok Gluta capsules: Safe ba sa liver? (Archived), March 25, 2023 National Institute of Diabetes and Digestive and Kidney Diseases, Definition & Facts of NAFLD & NASH, April 2021 National Institute of Diabetes and Digestive and Kidney Diseases, Symptoms & Causes of NAFLD & NASH, April 2021 National Library of Medicine (BMC Gastroenterology), Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study, Aug
Animals were monitored at least twice daily throughout the studies, including pre- and post-dose observations on dosing days
Eligible Medicare beneficiaries can now access Wegovy injection and pill for a $50 monthly copay through the program, which runs through the end of 2027